Lung cancer is a significant health concern due to late diagnosis. Researchers at MIT have developed nanosensors for lung cancer proteins, detectable in urine. The technology offers a noninvasive, fast, and accessible alternative to current screening methods. Challenges include potential interference factors and the need for further human testing.
Naar een andere taal
vanuit de broninhoud
www.medscape.com
Belangrijkste Inzichten Gedestilleerd Uit
by Christina om www.medscape.com 01-19-2024
https://www.medscape.com/viewarticle/how-simple-urine-test-could-reveal-early-stage-lung-cancer-2024a10001ibDiepere vragen